These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH; J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032 [TBL] [Abstract][Full Text] [Related]
4. Surgical treatment of primary lung cancer with synchronous brain metastases. Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases. Hashimoto T; Kobayashi Y; Ishikawa Y; Tsuchiya S; Okumura S; Nakagawa K; Tokuchi Y; Hayashi M; Nishida K; Hayashi S; Hayashi J; Tsuchiya E Cancer Res; 2000 Nov; 60(22):6472-8. PubMed ID: 11103815 [TBL] [Abstract][Full Text] [Related]
6. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone. Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805 [TBL] [Abstract][Full Text] [Related]
7. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470 [TBL] [Abstract][Full Text] [Related]
8. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer. Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2? Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193 [TBL] [Abstract][Full Text] [Related]
11. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk. Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134 [TBL] [Abstract][Full Text] [Related]
12. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer. Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203 [TBL] [Abstract][Full Text] [Related]
13. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113 [TBL] [Abstract][Full Text] [Related]
14. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors. Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650 [TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. Lally BE; Zelterman D; Colasanto JM; Haffty BG; Detterbeck FC; Wilson LD J Clin Oncol; 2006 Jul; 24(19):2998-3006. PubMed ID: 16769986 [TBL] [Abstract][Full Text] [Related]
16. Survival of patients with true pathologic stage I non-small cell lung cancer. Cerfolio RJ; Bryant AS Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920 [TBL] [Abstract][Full Text] [Related]
17. Variability in defining T1N0 non-small cell lung cancer impacts locoregional failure and survival. Saynak M; Hubbs J; Nam J; Marks LB; Feins RH; Haithcock BE; Veeramachaneni NK Ann Thorac Surg; 2010 Nov; 90(5):1645-9; discussion 1649-50. PubMed ID: 20971280 [TBL] [Abstract][Full Text] [Related]
18. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer. Zhou X; Kemp BL; Khuri FR; Liu D; Lee JJ; Wu W; Hong WK; Mao L Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539 [TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma. Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424 [TBL] [Abstract][Full Text] [Related]
20. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival. Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]